Exploration of adverse event profiles for glofitamab: A disproportionality analysis using the FDA adverse event reporting system. Zhou M, Jiang C, Su C. PLoS One 2025;20:e0336151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou M, Jiang C, Su C. Exploration of adverse event profiles for glofitamab: A disproportionality analysis using the FDA adverse event reporting system. PLoS One 2025;20:e0336151.
PMID: 41187120